From: Noncoding RNAs in cancer therapy resistance and targeted drug development
NcRNA | NCT number | Clinical trials | Cancer | Phases |
---|---|---|---|---|
miR-31 miR-210 | NCT03684707 | Cancer chemoprevention by metformin hydrochloride compared to placebo in oral potentially malignant lesions | Oral cancer | Phase 4 |
miR-31-3p miR-31-5p | NCT03362684 | PETACC-8 miR-31-3p and miR-31-5p ancillary study | Colorectal Cancer | Phase 3 |
miR-34a | NCT02862145 | Pharmacodynamics study of MRX34, microRNA liposomal injection in melanoma patients with biopsy accessible lesions | Melanoma | Phase 1 Phase 2 |
miR-34a | NCT01829971 | A multicenter phase I study of MRX34, microRNA miR-RX34 liposomal injection | Primary liver cancer, SCLC, lymphoma, multiple myeloma, renal cell carcinoma | Phase 1 |
miR-10b | NCT01849952 | Evaluating the expression levels of microRNA-10b in patients with gliomas | Glioma | Recruiting |
miR-29b | NCT02009852 | Observational study to explore the prognostic value of miR-29b in tissue, blood, and saliva | Oral cancer | Recruiting |
miR-29 family | NCT01927354 | Observational study to investigate the role of microRNA in Twist1-mediated cancer metastasis | Head and neck squamous cell carcinoma | Recruiting |
miRNA-100 | NCT02950207 | Prospective observational study of antitumor activity correlation between hormonal therapy and expression miRNA100 | Breast cancer | Recruiting |
MiR-155 | NCT03591367 | The potential role of microRNA-155 and telomerase reverse transcriptase in diagnosis of non-muscle invasive bladder cancer and their pathological correlation | Bladder cancer | Recruiting |
miR-16 | NCT02369198 | MesomiR 1: a phase I study of TargomiRs as 2nd or 3rd line treatment for patients with recurrent MPM and NSCLC | Malignant pleural mesothelioma, non-small cell lung cancer | Phase 1 |
miR-21 miR-20a-5 miR-103a-3p miR-106b-5p miR-143-5p miR-215 | NCT02466113 | A 6 microRNA tool for stratifying stage II colon cancer of receiving adjuvant chemotherapy | Colon cancer | Recruiting |
miR-221 miR-222 | NCT02928627 | Clinical significance of hepatic and circulating microRNAs miR-221 and miR-222 in hepatocellular carcinoma | Hepatocellular carcinoma | Recruiting |
miR-122 | NCT03687229 | The effect of DAAs on miRNA-122 and insulin resistance in chronic HCV patients | Chronic hepatitis C, hepatocellular carcinoma | Not yet recruiting |
MiR-25 | NCT03432624 | Detection of microRNA-25 in the diagnosis of pancreatic cancer | Carcinoma, pancreatic ductal | Not yet recruiting |
HOTAIR | NCT03469544 | Long non-coding RNA HOTAIR and Midkine as biomarkers in thyroid cancer | Thyroid cancer | Recruiting |
THRIL,PACER | NCT03057171 | A study on the gastrointestinal disease and helicobacter pylori controlled long non-coding RNA | Stomach cancer | Recruiting |